Literature DB >> 18472922

The Effect of Lyso-PAF on Ciliary Activity of Human Paranasal Sinus Mucosa in vitro.

T Ganbo1, K Hisamatsu, H Inoue, T Nakajima, Y Murakami.   

Abstract

The effect of lyso-PAF on ciliated cells was investigated in vitro. Normal mucosa was surgically obtained from human paranasal sinuses and incubated in the form of tissue culture. Ciliated epithelium was magnified under an inverted microscope, and ciliary movement was photo-electrically measured. Ciliary activity was significantly inhibited by 10(-8) M lyso-PAF and could be restored. The effect of lyso-PAF was completely blocked by CV-6209, a specific PAF antagonist. The PAF concentration in the incubation medium of lyso-PAF was determined by radioimmunoassay, because PAF is a well known inhibitor of ciliary activity. PAF gradually increased and after 20 min reached its maximal level. These findings indicated the existence of an enzyme in the paranasal sinus mucosa, by which lyso-PAF is converted to PAF, and that lyso-PAF can inhibit ciliary activity by means of PAF.

Entities:  

Year:  1994        PMID: 18472922      PMCID: PMC2367016          DOI: 10.1155/S0962935194000074

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  11 in total

1.  Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.

Authors:  M Misawa; S Iwamura
Journal:  Jpn J Pharmacol       Date:  1990-10

2.  Mucosal dysfunction and damage induced by platelet activating factor (PAF).

Authors:  T Ganbo; K Hisamatsu
Journal:  Acta Otolaryngol       Date:  1990 Nov-Dec       Impact factor: 1.494

3.  Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore.

Authors:  T C Lee; B Malone; S I Wasserman; V Fitzgerald; F Snyder
Journal:  Biochem Biophys Res Commun       Date:  1982-04-29       Impact factor: 3.575

4.  Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.

Authors:  K F Chung; H Aizawa; G D Leikauf; I F Ueki; T W Evans; J A Nadel
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

5.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

6.  Activation of 1-alkyl-2-lysoglycero-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes.

Authors:  F Alonso; M G Gil; M Sánchez-Crespo; J M Mato
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

7.  Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages.

Authors:  E Ninio; J M Mencia-Huerta; F Heymans; J Benveniste
Journal:  Biochim Biophys Acta       Date:  1982-01-15

8.  Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro.

Authors:  T Ganbo; K Hisamatsu; T Nakazawa; A Kamijo; Y Murakami
Journal:  Rhinology       Date:  1991-09       Impact factor: 3.681

9.  Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.

Authors:  R L Wykle; B Malone; F Snyder
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

10.  Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.

Authors:  F M Cuss; C M Dixon; P J Barnes
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.